Paroxetine, sold under the brand names Paxil and Seroxat among others, is an antidepressant of the selective serotonin reuptake inhibitor class.
| FactSnippet No. 1,124,787 |
Paroxetine, sold under the brand names Paxil and Seroxat among others, is an antidepressant of the selective serotonin reuptake inhibitor class.
| FactSnippet No. 1,124,787 |
Paroxetine was approved for medical use in the United States in 1992 and initially sold by GlaxoSmithKline.
| FactSnippet No. 1,124,788 |
Paroxetine is primarily used to treat major depressive disorder, obsessive-compulsive disorder, post-traumatic stress disorder, social anxiety disorder, and panic disorder.
| FactSnippet No. 1,124,789 |
Paroxetine was the first antidepressant approved in the United States for the treatment of panic disorder.
| FactSnippet No. 1,124,790 |
Paroxetine has demonstrated efficacy for the treatment of social anxiety disorder in adults and children.
| FactSnippet No. 1,124,791 |
Paroxetine is approved for treatment of PTSD in the United States, Japan and Europe.
| FactSnippet No. 1,124,792 |
Paroxetine has been shown to be an inhibitor of G protein-coupled receptor kinase 2 .
| FactSnippet No. 1,124,793 |
Paroxetine is the most potent and one of the most specific selective serotonin reuptake inhibitors .
| FactSnippet No. 1,124,794 |
Paroxetine was approved for medical use in the United States in 1992 and initially sold by GlaxoSmithKline.
| FactSnippet No. 1,124,795 |
Paroxetine has been identified as a potential disease-modifying osteoarthritis drug.
| FactSnippet No. 1,124,796 |